Abstract
Unresectable oral melanoma is often treated with radiation therapy (RT) and may show a temporary response to therapy. The clinical stage is one of the well-known prognostic factors for canine oral melanoma. However, the factors that directly affect the response to RT have remained unclear. This study aimed to validate the risk factors for recurrence after RT. Sixty-eight dogs with oral melanomas were included in this study. All dogs were treated with palliative RT using a linear accelerator without adjuvant therapies. After RT, the time to local recurrence (TTR) and overall survival (OS) were evaluated using the log-rank test. As a result, clinical stage and response to therapy were the significant independent prognostic factors in the multivariate analysis. The presence of local bone lysis and non-combination with cytoreductive surgery were associated with a worse response to RT. Immunohistochemical analysis for hypoxia-inducible factor-1α indicated that tumor cells invading the bone are under hypoxic conditions, which may explain a poorer efficiency of RT in dogs with bone lysis. In conclusion, clinical stage and combination with debulking surgery were needed to improve the efficiency of RT.
Reference31 articles.
1. Vaill, D.M., Thamm, D.H., and Liptak, J.M. (2020). Withrow & MacEwen’s Small Animal Clinical Oncology, Elsevier. [6th ed.].
2. Canine oral melanoma;Bergman;Clin. Tech. Small Anim. Pract.,2007
3. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006–2012);Kawabe;J. Am. Vet. Med. Assoc.,2015
4. A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol;Baja;Vet. Comp. Oncol.,2022
5. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation;Proulx;Vet. Radiol. Ultrasound,2003